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Abstract
Background: Polymicrobial infections in adults and children are associated with increase in mortality, duration of
intensive care and healthcare costs. Very few studies have characterized polymicrobial bloodstream infections in
the neonatal unit. Considerable variation has been reported in incidence of polymicrobial infections and associated
clinical outcomes. We characterized the risk factors and outcomes of polymicrobial bloodstream infections in our
neonatal units in a tertiary hospital in North America.
Methods: In a retrospective case control study design, we identified infants in the neonatal intensive care unit
with positive blood cultures at Texas Children’s Hospital, over a 16-year period from January 1, 1997 to December
31, 2012. Clinical data from online databases were available from January 2009 to December 2012. For each
polymicrobial bloodstream infection (case), we matched three infants with monomicrobial bloodstream infection
(control) by gestational age and birth weight.
Results: We identified 2007 episodes of bloodstream infections during the 16 year study period and 280 (14%) of
these were polymicrobial. Coagulase-negative Staphylococcus, Enterococcus, Klebsiella and Candida were the most
common microbial genera isolated from polymicrobial infections. Polymicrobial bloodstream infections were
associated with more than 3-fold increase in mortality and an increase in duration of infection. Surgical intervention
was a significant risk factor for polymicrobial infection.
Conclusion: The frequency and increased mortality emphasizes the clinical significance of polymicrobial
bloodstream infections in the neonatal intensive care unit. Clinical awareness and focused research on neonatal
polymicrobial infections is urgently needed.
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Background
Polymicrobial infections increase mortality more than
2-fold in adults and children, increase length of hospital
stay and healthcare costs [1,2]. Risk factors for polymicro-
bial infections in children and adults include the presence
of a central venous catheter, administration of parenteral
nutrition, gastrointestinal pathology, especially short gut
syndrome, use of broad-spectrum antibiotics and immu-
nosuppression [1,3,4].
Neonatal polymicrobial infections are less well charac-
terized compared to those in children or adults. Increased
survival of extremely premature infants at the edge of via-
bility, dependence on catheters and parenteral nutrition
(PN), and antibiotic therapy may predispose to polymicro-
bial infections in neonates. The frequency of neonatal
polymicrobial bloodstream infections reported in clinical
studies varies from 4 to 24% of all bloodstream infections
[5-10]. A standard definition for neonatal polymicrobial
infections is lacking and the incidence varies from study
to study partly due to variability in definition, neonatal
population and practices [11]. Few studies have focused
on polymicrobial infections in neonates, especially on risk
factors and clinical outcomes in the western world
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[10-12]. In a neonatal review, the mortality due to
polymicrobial infections was 3-fold greater than that
of monomicrobial infections (70% vs. 23%) [10]. Organisms
that are commonly implicated in neonatal polymicrobial
bloodstream infections are coagulase-negative staphylo-
coccus (CONS), Candida spp., Staphylococcus aureus and
Enterococcus spp. [1,9,13-16]. A common risk factor ap-
pears to be multi-species biofilm infections originating
from indwelling medical devices, notably indwelling vascu-
lar catheters or endotracheal tubes [1,17].
Polymicrobial bloodstream infections may be defined
as multiple organisms isolated during an infectious epi-
sode including those from a single blood specimen [1] or
more restrictively as isolation of more than one organism
from a single blood specimen only [11,12,17]. Different
definitions may partly explain the varying incidence of
polymicrobial bloodstream infections reported. Bizzarro et
al. (Yale, 1989-2006) and Faix et al. (Ann Arbor, 1971-
1986) have reported the only two studies on neonatal
polymicrobial infections from North America, [10,11].
Changing epidemiology of neonatal infections dictates a
need to update and understand the epidemiology of poly-
microbial infections in the hospitalized infant [11]. Lack of
data on polymicrobial infections from our neonatal unit
and concern of significant increase in mortality, morbidity
and healthcare costs due to polymicrobial infections
prompted us to investigate its frequency, risk factors and
clinical outcomes at Texas Children’s Hospital (TCH).
Methods
We hypothesized that polymicrobial infections com-
prise > 5% of bloodstream infections in infants residing in
the neonatal intensive care units, have identifiable risk
factors and are associated with higher mortality and
morbidity than monomicrobial infections. We tested
our hypothesis by performing a single center, retro-
spective, matched case-control study during a 16 year
study period. Our study protocol was approved by the
Institutional Review Board at Baylor College of Medicine,
Houston. We followed the STROBE guidelines in report-
ing this study [18].
Identification of cases and controls
We identified blood culture positive infants from the
clinical microbiology database, who were admitted to
the neonatal intensive care units (NICUs) III and II at
TCH from January 1, 1997 to December 31, 2012. In-
fants more than 28 days of age in the NICU at the time
of the infection and those admitted from home to the
NICU with positive blood cultures were also included.
The data in the clinical microbiology database is entered
by the microbiologist and all positive and negative
cultures including those regarded as contaminants are
recorded. The tertiary NICU at TCH has approximately
1500 admissions per year including inborn and outborn
transferred neonates (ranged from 1338 to 1547 during
the years 2009 to 2012). Very low birth weight (VLBW,
birth weight < 1500 g) infant admissions ranged from
222 to 291 infants during the years 2009 to 2012.
Definitions
Polymicrobial bloodstream infection was defined as: i)
isolation of more than one organism from a single blood
culture specimen and ii) isolation of more than one organ-
ism in different blood culture specimens during the same
bloodstream infectious episode. We defined ‘bloodstream
infection episodes’ as time-periods associated with positive
blood cultures [1] and the infection episode was consid-
ered resolved when at least two subsequent blood cultures
performed every 24 hrs were negative. Usually when an
organism is isolated from a blood culture specimen, blood
cultures are repeated every 24 hr till two blood culture
specimens are negative for organisms. Our neonatal units
used only aerobic blood cultures and it is not routine to
perform anaerobic blood cultures for the evaluation of
neonatal sepsis. Single specimen polymicrobial infections
were defined as more than one organism isolated from the
same blood culture specimen. We also collected data re-
garding duration of the infection episode from culture
positivity to culture negativity. For each polymicrobial
bloodstream infection (case), we selected three gestational
age matched neonates with comparable birth weights with
monomicrobial bloodstream infection (control) during the
time period 2009 to 2012. The matching was performed
by an investigator who was blinded to neonatal risk factors
and outcomes. An infant who had both polymicrobial and
monomicrobial infections was included in the polymi-
crobial infection category for evaluation of neonatal out-
comes because of the possibility that even one exposure to
polymicrobial infection may increase mortality or mor-
bidity. If an infant had multiple episodes of polymicrobial
infections, the first polymicrobial infection episode was
analysed. Coagulase negative staphylococcal (CONS)
infections, skin flora (e.g. Micrococcus spp., Gamma
Streptococci) and organisms infrequent in neonates
(e.g. Bacillus spp.) were considered real infections when
grown from two clinical specimens and a single culture of
the above organisms were deemed contaminant and not
included in the analyses.
Clinical data collection
Neonatal clinical data including demographics, risk factors
and outcomes were identified by cross referencing our
institution’s neonatal clinical database (from Vermont
Oxford Network (VON) database), for a 4 year period
from January 1, 2009 to December 31, 2012. We collected
the following clinical data for the identified cases and con-
trols: demographic data (gestational age, birth weight, sex,
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age at the start of the infection episode and whether
inborn or outborn), parenteral nutrition (PN) administra-
tion and its duration, presence of intravenous catheters at
the time of the infectious episode (percutaneously inserted
central catheters and broviac catheters but excluded um-
bilical catheters). We excluded umbilical venous catheters
because our neonatal policy is to replace the umbilical
venous catheters in the first few days of life with percutan-
eously inserted central catheters (PICC) and hence most
umbilical lines lasted only a few days. Also, most of the
bloodstream infections occurred at a time when umbilical
catheters were no longer in place. We also collected data
on important clinical outcomes (mortality, length of hos-
pital stay, bronchopulmonary dysplasia, patent ductus
arteriosus (PDA), necrotizing enterocolitis (NEC, ≥ stage
2 by Bell’s classification), intraventricular hemorrhage
(IVH), periventricular leucomalacia (PVL) and retinopathy
of prematurity (ROP), intermittent positive pressure venti-
lation (IPPV) at 36 wks corrected gestational age (GA),
continuous positive airway pressure (CPAP) at 36 wks cor-
rected GA, high frequency oscillatory ventilation (HFOV),
inhaled nitric oxide (INO) therapy, extracorporeal mem-
brane oxygenation (ECMO), surgeries, direct hyperbi-
lirubinemia (direct bilirubin > 2 mg/dl or > 15% of total
bilirubin) congenital heart disease and congenital malfor-
mations. All outcomes were defined as per VON database
definitions.
Statistical analyses
Data were analyzed using STATA 11, Stata Corporation,
Dallas, USA. Infants with polymicrobial bloodstream
infections were compared with three gestational age and
birth weight matched infants with monomicrobial blood-
stream infections. Continuous data were analyzed for
statistical significance by the Student’s t test and categor-
ical data were analyzed by chi squared analyses. A p
value of < 0.05 was considered significant. A logistic re-
gression analysis was performed for binary outcomes
and odds ratios with 95% confidence intervals were esti-
mated. The outcome of mortality was analyzed adjusting
for ‘any surgery’ in the logistic regression model. Polymi-
crobial infections were used as the outcome of the logis-
tic regression analysis for risk factors and as a covariate
when assessing for neonatal outcomes. A subgroup ana-
lysis of VLBW infants was performed for mortality and
risk factors in the logistic regression model.
Results
We identified 2007 bacteremia episodes during a period of
16 years in patients admitted to the NICUs at TCH; 280
episodes (14%) were polymicrobial (Figure 1). The percent-
age of annual polymicrobial bacteremia varied during the
study period ranging from 6.3 to 18.6%. Polymicrobial
bacteremia identified in single blood specimens constituted
on an average of 56% (range 40 to 75%) during the 16 year
study period.
Microbes isolated from monomicrobial (controls) and
polymicrobial infections (cases) were similar but varied
in frequency (Table 1). Microbes isolated at greater fre-
quencies in polymicrobial infections were Candida spp.
(>3%), Enterococcus faecalis (>2-fold) and Klebsiella
pneumoniae (>2-fold). The most common combinations
of polymicrobial organisms were CONS and Candida
spp. (n = 6) and CONS and Enterococcus faecalis (n = 3).
Gram positive organisms were isolated more frequently
than gram negative organisms and the proportion of
gram positive to gram negative organisms were similar
in both monomicrobial (gram positive 51% and gram
negative 42%) and polymicrobial infections (gram positive
48% and gram negative 40%).
We compared clinical data pertaining to demographics,
risk factors and clinical outcomes between infants with
polymicrobial bacteremia and gestational age and birth-
weight matched infants with monomicrobial bacteremia
(data from January 2009 to December 2012) (Table 2). We
obtained neonatal data for 34 infants with polymicrobial
bacteremia and 102 matched infants with monomicrobial
bacteremia during that period. The demographics were
similar between infants with polymicrobial compared to
infants with monomicrobial bacteremia. As expected,
the gestational age (30.5 vs. 30.4 wk, p = 0.90) and
birth weights (1592 vs.1535 g, p = 0.77) were adequately
matched between controls and cases respectively. Male
sex and age at infection did not differ significantly
between cases and controls.
Figure 1 Frequency of polymicrobial bacteremia episodes. The
frequencies of neonatal bacteremia episodes are plotted against
the years from 1997 to 2012. The dark shaded portion of the bars
indicate polymicrobial component of the infectious episodes, which
ranged from 6.3 to 18.6% and on an average of about 14% during
the 16-year study period. There were significant decrease in the
number of infections and polymicrobial infections between the time
epochs, 1998-2009 and 2010-2012 (p < 0.01).
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We observed a significant difference between cases
and controls in terms of surgery other than for NEC
(p = 0.04) and any surgery (including NEC surgery) (p = 0.05,
borderline significance). We observed an increase in the
presence of a central venous catheter (97 vs. 91%, p =0.20)
and incidence of direct hyperbilirubinemia (50 vs. 32%,
p = 0.06) both of which did not reach statistical signifi-
cance. We did not observe any significant differences in
the proportion of infants receiving PN, days on PN, the in-
cidence of NEC, surgery for NEC, congenital heart disease
or congenital malformations between cases and controls.
We noted a significant difference in associated mortality
between controls and cases (47 vs. 20%), odds ratio adjus-
ted for ‘any surgery’, 4.3 [95% CI, 1.8 to 10.2] (p =
0.001). A significant increase in the duration of infec-
tion (culture positivity) was noted between cases and
controls (2.91 vs. 2.07 days, p = 0.02). No significant
differences were observed in length of hospital stay,
BPD, IPPV at 36 corrected wks, CPAP at 36 corrected
wks, HFOV, ECMO, PDA, severe IVH (IVH > grade 2),
PVL, severe IVH or PVL, ROP or severe ROP (ROP >
stage 2) (p > 0.05). An increase in INO therapy in cases
were noted (41 vs. 25%, p = 0.08) but was not statistically
significant.
In a subgroup analysis of VLBW infants, polymicrobial
infections compared to monomicrobial infections, had a
significantly higher mortality (OR 6.4 [95% CI 1.3 to
30.3], longer duration of infection (OR 1.4 [95% CI 1.04
to 1.8] and higher incidence of congenital malformations
(OR 17.7 [95% CI, 2.1 to 148.7).
Discussion
We performed a case-control study of neonatal polymi-
crobial infections in a tertiary hospital in North America,
and identified polymicrobial bloodstream infections in
nearly 14% of bloodstream infections. We also probed the
electronic neonatal clinical database over a four year
period from January 2009 to December 2012 for relevant
clinical data including risk factors and outcomes. We
observed that polymicrobial bloodstream infections were
associated with an increased mortality (>3-fold) and in-
creased duration of infection compared to monomicrobial
bloodstream infections. Surgical intervention excluding
NEC surgery was a significant risk factor for neonatal
polymicrobial infections.
The annual frequency of polymicrobial bloodstream
infections in our study was approximately 14% over a
16 year study period. The frequency of neonatal polymi-
crobial infections reported in literature is variable, ranging
from 3.9 to 25% [10-12,17,19-21]. Contaminated multi-
dose lipid emulsions were responsible for the high fre-
quency (25%) of polymicrobial infections in one study
[20]. In most studies that report neonatal infections, the
isolation of multiple organisms is often not discussed. The
higher frequency of polymicrobial infections in our study
compared to other reports in literature may be due to two
reasons. First is the varying definition of polymicrobial
infections in the different studies. We defined polymicro-
bial bloodstream infections as multiple organisms isolated
during an infectious episode including those from a single
blood specimen similar to Sutter et al., as we believe that
Table 1 Microbiology of monomicrobial and polymicrobial bloodstream infections
Monomicrobial infections data as n (%) Polymicrobial infections data as n (%)
CONS 16 (15.69) 12 (16.22)
Staphylococcus aureus 16 (15.69) 6 (8.11)
Streptococcus agalactiae 6 (5.88) 2 (2.70)
Candida albicans, C. parapsilosis, C. glabrata 7 (6.86) 7 (9.46)
Escherichia coli 18 (17.65) 5 (6.76)
Enterococcus faecalis, E. faecium 7 (6.86) 11 (14.86)
Enterobacter cloacae, E. aerogenes 8 (7.84) 5 (6.76)
Klebsiella pneumoniae, K. oxytoca 6 (5.88) 11 (14.86)
Pseudomonas aeruginosa 4 (3.92) 4 (5.41)
Bacillus spp. 4 (3.92) 1 (1.35)
Serratia marcescens 3 (2.94) 3 (4.05)
Others 7 (6.86) 7 (9.46)
Total 102 (100) 72 (100)
In monomicrobial bloodstream infections, 102 organisms were isolated from 102 infectious episodes. In polymicrobial bloodstream infections, 74 organisms were
isolated from 34 infectious episodes. ‘Others’ include Streptococcus salivarius, Citrobacter freundii, Clostridium tertium for monomicrobial infections and for
polymicrobial infections; they were Lactobacillus, Proteus mirabilis, Streptococcus sanguinus, Micrococcus spp., Acinetobacter baumanii complex and Gamma
Streptococcus. All the organisms in the ‘Others’ group was cultured at least twice from 2 different samples. Candida species, Enterococcus species and Klebsiella
species were isolated at higher frequencies in polymicrobial infections than monomicrobial infections. The most common combination of polymicrobial organisms
were CONS and Candida (n = 6) and CONS and Enterococcus fecalis (n = 3).
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this is a true reflection of a polymicrobial infection [1].
Other studies defined polymicrobial infections as multiple
pathogens isolated from a single blood specimen, which
may account for the lower incidence of polymicrobial in-
fections [11,12,17]. Using the latter definition the annual
frequency of polymicrobial bloodstream infections in our
study would be approximately 7.8%, comparable to the
10% frequency reported in North American by Bizzarro et
al. [11]. Secondly, increased incidence of polymicrobial
bloodstream infections in our study may also relate to the
large percentage of medically complex infants referred to
our NICU including infants requiring surgical interven-
tions, complex congenital heart disease, ECMO, abdom-
inal wall defects, short gut syndrome and other congenital
Table 2 Infant demographics, risk factors and outcomes in cases and controls
Monomicrobial infections (n = 102),
Mean [95% CI] or n (%)
Polymicrobial infections (n = 34),
Mean [95% CI] or n (%)
p value Odds ratio (OR) [95% CI]
Demographics
GA (wks) 30.5 [29.9, 31.1] 30.4 [29.4, 31.3] 0.90
Bwt (g) 1592 [1493, 1692] 1535 [1365, 1706] 0.77
Male sex, n (%) 56 (54) 17 (50) 0.65
Age at infection (days) 40.7 [35.8, 45.5] 37.7 [30.3, 45.0] 0.75
Inborn (%) 43 (41.2) 14 (41.2) 1.00
Risk factors
Catheter, n (%) 93 (91) 33 (97) 0.20 3.6 [0.4 to 29.1]
PN, n (%) 92 (90.2) 30 (88.2) 0.74
PN duration (days) 49.3 [43.9, 54.8] 47.5 [40.0, 55.1] 0.86
NEC (%) 24 (23.5) 7 (20.6) 0.72 0.8 [0.3 to 2.2]
NEC surgery (%) 18 (17.6) 6 (17.6) 1.00 1.0 [0.4 to 2.8]
Surgery other than NEC (%) 55 (53.9) 25 (73.5) 0.04* 2.4 [1.0 to 5.6]
Any surgery (%) 56 (54.9) 25 (73.5) 0.05* 2.3 [1.0 to 5.4]
Direct hyperbilirubinemia (%) 33 (32.4) 17 (50.0) 0.06 2.1 [1.0 to 4.6]
Congenital heart disease (%) 28 (27.5) 9 (26.5) 0.91 1.0 [0.4 to 2.3]
Congenital malformations (%) 31 (30.4) 15 (44.1) 0.14 1.8 [0.8 to 4.0]
Outcomes
Mortality (%) 19.6 47.1 0.001 * 4.3 [1.8 to 10.2] Logistic
model adjusted for surgery
Hospital stay (days) 101.7 [93.6, 109.8] 100.5 [88.1, 112.9] 0.99
Infection duration (days) 2.1 [1.9, 2.2] 2.9 [2.5, 3.3] 0.02*
BPD (%) 35 (34.3) 9 (26.5) 0.40 0.7 [0.3 to 1.6]
IPPV at 36wks (%) 24 (23.7) 12 (35.3) 0.19 1.8 [0.8 to 4.1]
CPAP at 36wks (%) 8 (7.8) 4 (11.8) 0.49 1.6 [0.4 to 5.6]
HFOV (%) 33 (32.4) 10 (29.4) 0.75 0.9 [0.4 to 2.0]
ECMO (%) 16 (15.7) 6 (17.6) 0.79 1.2 [0.4 to 3.2]
INO (%) 26 (25.5) 14 (41.2) 0.08 2.1 [0.9 to 4.6]
INO or HFOV or ECMO (%) 52 (50.9) 18 (52.9) 0.84 1.1 [0.5 to 2.4]
PDA (%) 13 (32.4) 33 (38.2) 0.53 1.3 [0.6 to 2.9]
ROP (%) 12 (11.8) 4 (11.8) 1.00 1.0 [0.3 to 3.3]
Severe ROP (%) 7 (6.9) 3 (8.8) 0.70 1.3 [0.3 to 5.4]
ROP surgery (%) 6 (5.9) 2 (5.9) 1.00 1.0 [0.2 to 5.2]
Severe IVH (%) 18 (17.6) 5 (14.7) 0.69 0.8 [0.3 to 2.4]
Severe IVH or PVL (%) 19 (19.6) 5 (14.7) 0.52 0.8 [0.3 to 2.2]
95% CI- 95% confidence intervals, Bwt-Birth weight, GA-gestational age, PN- parenteral nutrition, NEC- necrotizing enterocolitis, BPD-bronchopulmonary dysplasia,
IPPV- Intermittent positive pressure ventilation, CPAP- continuous positive airway pressure, HFOV- High frequency oscillatory ventilation, INO- inhaled nitric oxide,
ECMO- extracorporeal membrane oxygenator, PDA-patent ductus arteriosus, ROP-retinopathy of prematurity, IVH-intraventricular hemorrhage, PVL- periventricular
leucomalacia, severe IVH- IVH > grade 2, severe ROP- ROP > stage 2. *p values < 0.05.
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anomalies. This complex group of infants often requires
indwelling vascular catheters for parenteral nutrition or
medications for extended periods of time. The annual fre-
quency of polymicrobial bacteremia in the neonatal inten-
sive care unit in our study varied from 6.3 to 18.6% of all
bacteremia during the 16-year study period. This annual
variation may be in part due to expansion of the NICU,
changes in the case-mix and referral patterns, nursing pol-
icy changes or implementation of catheter care bundles.
There were significant decrease in the number of infec-
tions and polymicrobial infections between the time
epochs, 1998-2009 and 2010-2012 (p < 0.01). We did not
note any significant differences in the number of admis-
sions of VLBW and ELBW infants. A dedicated vascular
access team was formed in June 2009 followed by better
implementation of catheter care bundles in June 2009,
which along with increased compliance with hand hygiene
and other infection control measures may have contrib-
uted to the decrease in infections.
In our study, cases and controls had similar demograph-
ics, a mean gestational age of approximately 30 weeks,
birth weight of approximately 1500 g, similar male to
female ratio and similar percentage being inborn. We
focused on risk factors reported for polymicrobial infec-
tions in existing literature. The average age at the onset of
the infections was 41 days in controls and 38 days in cases
and hence all infections were in the late onset sepsis
category and mostly occurred beyond the first 28 days of
life. Almost all of the infections were late-onset infections
and hence we did not collect data on risk factors for early
onset sepsis such as maternal prolonged rupture of mem-
branes, group B streptococcus colonization, urinary tract
infection or chorioamnionitis. Subgroups of infections in
neonates less than 28 days of age or those that were
admitted from home were too small for meaningful com-
parisons. We noted a significant association of polymicro-
bial infections with surgery other than NEC and a trend
towards association with direct jaundice. Cases had a
higher incidence of central venous catheter compared to
controls (97 vs. 91%, p = 0.20) but this association was not
statistically significant.
In our case-control study, we observed more than
3-fold increase in associated mortality in neonates
with polymicrobial bacteremia, but the retrospective
and database oriented nature of our study precludes
any conclusions of causality. Mortality due to polymicro-
bial infections has been reported to be at least 2-fold more
than that of monomicrobial infections both in adults and
children [1,2]. Faix et al. reported that mortality due to
polymicrobial infections in neonates is increased almost
3-fold in his study of 15 cases of polymicrobial infections
in 1971-86 [10]. More recent studies by Bizzarro et al.
(study period 1989-2006), Tsai et al (study period 2004 to
2011) and Gupta et al. (1 year period in early 2000) did not
report an increase in attributable mortality to polymicro-
bial infections in their studies [11,12,17]. The variability in
mortality rates reported by different studies on polymicro-
bial infections may be multifactorial including differences
in study design, variable definitions of polymicrobial infec-
tions, patient population, study periods, virulence of the
organisms isolated or other unidentified factors [11]. The
mechanisms for increased mortality in polymicrobial in-
fections are not clear. Similar increases in mortality are
observed in animal models of systemic and local polymi-
crobial infections [22-25]. We have observed increased
catheter infection and systemic dissemination in a poly-
microbial biofilm catheter infection model compared to
monomicrobial infection [11]. The increased mortality
may also arise from inherent host vulnerability that causes
the infection in the first place (e.g. prematurity, short gut)
or facilitation of one infection by the other (synergism)
[26]. Polymicrobial interactions in polymicrobial envi-
ronments such as a mixed-species biofilms on catheters
may induce a host of synergistic mechanisms including
quorum sensing, induction of virulence among others that
may contribute to enhanced mortality or morbidity of the
host [12].
We also noted an increase in the duration of infection
in cases compared to controls, which may be due to
increased host susceptibility or a synergistic effect of the
polymicrobial infection. We did not observe any differences
in length of hospital stay or other clinically relevant neo-
natal outcomes such as BPD, IPPV or CPAP at 36 corrected
weeks, HFOV, ECMO, ROP, NEC or IVH or PVL. We ob-
served an increase in the use of INO therapy in cases com-
pared to controls, which was not statistically significant.
The organisms isolated in our study were mostly similar
in both monomicrobial and polymicrobial bloodstream
infections, similar in antibiotic susceptibility patterns and
comparable to those organisms from polymicrobial infec-
tions reported in literature. The most common organisms
isolated in both monomicrobial and polymicrobial infec-
tions were CONS, Staphylococcus aureus, Escherichia coli,
Enterococcus species, Klebsiella spp. and Candida spp.
Infections due to Candida spp., Enterococcus species and
Klebsiella spp. increased in frequency in cases compared
to controls. The most frequent polymicrobial combina-
tions were CONS with Candida spp. and other organisms
with Enterococcus faecalis, similar to reported literature
[1,14,27]. Studies from Asia, by Tsai et al. and Gupta et al.
report a high incidence of Gram negative infections
(approximately 60%) in the polymicrobial group [12,17].
In the North American study by Bizarro et al., polymicro-
bial infections were preponderantly caused by Gram posi-
tive organisms (77%) similar to our study [11]. Geographic
variations in organisms isolated from neonatal polymicro-
bial infections and their antibiotic susceptibility patterns
may partly explain the variation in mortality and morbidity
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across the world due to polymicrobial infections. In our
study we did not discern any differences in the treatment
regimens used to treat polymicrobial infections and mono-
microbial infections that could explain the differences in
mortality. Polymicrobial infections were treated adequately
for all the organisms isolated and duration of therapy
was consistent with our written neonatal guidelines.
Limitations of our study include being a retrospective,
observational, case-control study. Bloodstream episodes
were identified from the clinical microbiology database
and hence the clinical data associated with the infection
or their severity were not available. The clinical risk
factors and outcomes were identified from the clinical
database, which was available only for a 4 year period.
Being a retrospective study, it is difficult to assign a
causal relationship to the increased mortality associated
with polymicrobial infections in our study. We did not
assess long term developmental or growth outcomes as
longitudinal assessment data were not available.
The human microbiome project and other microbiome
studies emphasize the polymicrobial nature of organism
communities in the human body [28,29]. The availability
of molecular culture-independent methods for detection
of sepsis may increase the identification of polymicrobial
infections [30]. Guidelines or recommendations for the-
rapeutic and preventive strategies against polymicrobial
infections do not exist. Prolonged therapy with antibi-
otics targeting all organisms isolated in a polymicrobial
infection and removing infected catheters remain the
mainstay in therapy. Defining the epidemiology and clin-
ical impact of polymicrobial infections may be the first
step towards delineating optimal therapy and clinical
outcomes. Preventive strategies should emphasize cath-
eter care bundles that decrease central line associated
bloodstream infections. Focused research is necessary to
prevent and treat polymicrobial infections to improve
clinical outcomes in the vulnerable neonate.
Conclusions
The main aim of the study was to investigate the fre-
quency of polymicrobial infections in our tertiary neonatal
intensive care unit, understand its impact on neonatal out-
comes and promote research in the management of these
infections. Polymicrobial bacteremia is common in neo-
nates and comprises nearly 14% of all infectious episodes.
The most common organisms in neonatal polymicrobial
infections are CONS, S. aureus, Enterococcus species,
E. coli, and Candida species. Surgical intervention is a
significant risk factor for neonatal polymicrobial infections.
We observed a more than 3-fold increase in mortality in
infants with polymicrobial bacteremia and a significant
increase in duration of the bacteremia. Research focused to
prevent and to improve clinical outcomes in neonatal poly-
microbial infections is urgently needed.
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